<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0135">
 <element-citation publication-type="journal" id="sbref0135">
  <person-group person-group-type="author">
   <name>
    <surname>Blackard</surname>
    <given-names>J.T.</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Rouster</surname>
    <given-names>S.D.</given-names>
   </name>
   <name>
    <surname>Karns</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Horn</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Kottilil</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shata</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Sherman</surname>
    <given-names>K.E.</given-names>
   </name>
  </person-group>
  <article-title>CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication 
   <italic>in vitro</italic>
  </article-title>
  <source>PLoS One</source>
  <volume>14</volume>
  <year>2019</year>
  <object-id pub-id-type="publisher-id">e0224523</object-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0224523</pub-id>
 </element-citation>
</ref>
